Landstinget i Värmland Report issue

Government Phase 2 Phase 4

Organization Overview

First Clinical Trial
2002
NCT01008488
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Landstinget i Värmland